Pular para o conteúdo
Merck
  • The differentially expressed gene signatures of the Cullin 3-RING ubiquitin ligases in neuroendocrine cancer.

The differentially expressed gene signatures of the Cullin 3-RING ubiquitin ligases in neuroendocrine cancer.

Biochemical and biophysical research communications (2022-11-12)
Jong-Uk Park, Dong-Kyu Kim, Ji-Ye Kim, Jae-Hyun Jo, Yeong-Mu Kim, Dong-Hyun Jung, Hye-Ji Kim, Seon-Mi Ok, Hyo Je Cho, Sangjune Kim, Christophe E Redon, Mirit I Aladjem, Sang-Min Jang
RESUMO

Cullin-RING ubiquitin E3 ligase (CRLs) composed of four components including cullin scaffolds, adaptors, substrate receptors, and RING proteins mediates the ubiquitination of approximately 20% of cellular proteins that are involved in numerous biological processes. While CRLs deregulation contributes to the pathogenesis of many diseases, including cancer, how CRLs deregulation occurs is yet to be fully investigated. Here, we demonstrate that components of CRL3 and its transcriptional regulators are possible prognosis marker of neuroendocrine (NE) cancer. Analysis of Cancer Cell Line Encyclopedia (CCLE) through the CellMinerCDB portal revealed that expression of CRL3 scaffold Cullin 3 (CUL3) highly correlates with NE signature, and CUL3 silencing inhibited NE cancer proliferation. Moreover, subset of 151 BTB (Bric-a-brac, Tramtrack, Broad complex) domain-containing proteins that have dual roles as substrate receptors and adaptor subunits in CRL3, as well as the expression of transcription factors (TFs) that control the transcription of BTB genes were upregulated in NE cancer. Analysis using published ChIP-sequencing data in small cell lung cancer (SCLC), including NE or non-NE SCLC verified that gene promoter of candidates which show high correlation with NE signature enriched H3K27Ac. These observations suggest that CRL3 is a master regulator of NE cancer and knowledge of specifically regulated CRL3 genes in NE cancer may accelerate new therapeutic approaches.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Anti-α-tubulina monoclonal, clone DM1A, ascites fluid
Sigma-Aldrich
Anticorpo anti-histona H3, CT, pan, serum, Upstate®
Sigma-Aldrich
Anti-KCTD16 antibody produced in rabbit, Prestige Antibodies® Powered by Atlas Antibodies, affinity isolated antibody, buffered aqueous glycerol solution